Evidence map›Paper›PMID 41279326›Full record

ArticlebioRxiv : the preprint server for biology2025

NPM1 mislocalization mediated by RNA Pol I inhibition alters chromatin landscape.

Pierre-Olivier Estève, Sagnik Sen, Karthikeyan Raman, Ashwin Unnikrishnan, Sriharsa Pradhan

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pierre-Olivier EstèveNew England Biolabs Inc, 240 County Road, Ipswich, MA 01938, USA.
Sagnik SenNew England Biolabs Inc, 240 County Road, Ipswich, MA 01938, USA.ORCID 0000-0002-3362-1677
Karthikeyan RamanNew England Biolabs Inc, 240 County Road, Ipswich, MA 01938, USA.
Ashwin UnnikrishnanNew England Biolabs Inc, 240 County Road, Ipswich, MA 01938, USA.ORCID 0000-0001-5168-8755
Sriharsa PradhanNew England Biolabs Inc, 240 County Road, Ipswich, MA 01938, USA.

Funding

Ultrasensitive multiomic platform using epitope-targeted DNA methylation mappingR44HG011875 · NHGRI · EPICYPHER, INC. · PI KEOGH, MICHAEL-CHRISTOPHER, VENTERS, BRYAN J · 2022 to 2024
$2.9M
NHGRI NIH HHS R44 HG011875
6 · The paper itself

Abstract

RNA polymerase I inhibition affects rRNA synthesis from rDNA clusters residing in nucleolar organizer regions (NORs). Here we have demonstrated RNA Pol I inhibition disrupts nucleolar architecture, NPM1 localization, and alters the chromatin landscape using coordinated eraser and writer enzymes. siRNA mediated depletion or dissociation of NPM1 allows HDAC1 loading on the chromatin. HDAC1 mediated deacetylation of H3K9ac creates H3K9 that undegoes SUV39H1-mediated methylation. The stripping of active histone marks leads to enrichment of repressive H3K9me3 in the genome. These altered chromatin landscape corroborates with loss of genome-wide chromatin accessibility and DNA hypermethylation mediated by DNMT1. Chromatin architectural analysis revealed disrupted nucleolar associated domains (NADs) transforming to lamin associated domains (LADs) with specific histone signatures and repressive states. The 3D nuclear architecture was remodeled by A/B compartments reorganization and loss of Hi-C loops at the H3K9ac depleted sites.

Identifiers

PMID41279326
PMCPMC12636500

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.